The treatment of leprosy and its acute complications.
D000814:Aniline Compounds / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use; D004844:Epistaxis / Q000209:etiology / Q000628:therapy; D005132:Eye Manifestations; D006801:Humans; D007097:Imines / Q000627:therapeutic use; D007916:Lepromin; D007918:Leprosy / Q000150:complications / Q000276:immunology / Q000628:therapy*; D009461:Neurologic Manifestations; D010146:Pain / Q000188:drug therapy; D010619:Phenazines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D013890:Thiourea / Q000627:therapeutic use
D000814:Aniline Compounds; D000900:Anti-Bacterial Agents; D007097:Imines; D010619:Phenazines; D013449:Sulfonamides; D013450:Sulfones; D007916:Lepromin; D003622:Dapsone; D013890:Thiourea; D013828:Thioacetazone